Genisphere LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genisphere LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10522
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genisphere LLC (Genisphere) is a nanotechnology company that provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapeutics. It develops pipeline products in the areas of oncology and ocular. Genisphere offers GL 249, a preventative treatment of Posterior Capsule Opacification (PCO), a vision impairing disease that occurs in adults and children following cataract surgery. It also develops GL 233 which is used in the treatment of ovarian cancer. The company’s design stage product pipeline includes GS-2A3, GL-23X, GL-246, and GL-238 intended for the treatment of ovarian cancer, pancreatic cancer, triple negative breast cancer and glioblastoma respectively. Genisphere is headquartered in Hatfield, Pennsylvania, the US.

Genisphere LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genisphere LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genisphere LLC, Medical Devices Deals, 2012 to YTD 2018 9
Genisphere LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genisphere LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Genisphere Raises USD7 Million in Financing 11
Genisphere Raises USD2 Million in Venture Financing 12
Partnerships 13
Genisphere Enters into Research Agreement with Sidney Kimmel 13
Genisphere Enters into Agreement with Inserm 14
Genisphere Enters into Research Agreement with University of Maryland 15
MedImmune Enters into Agreement with Genisphere 16
Genisphere Enters into Research Agreement with University of Pennsylvania 17
MultiCell Technologies Enters Into Agreement With Genisphere To Develop MCT-485 18
Genisphere Enters Into Agreement With Lankenau Institute for Medical Research To Develop Nanotherapeutics 19
Licensing Agreements 20
Genisphere Receives License from LIMR Development 20
Equity Offering 21
Genisphere Raises USD4 Million in Private Placement of Shares 21
Genisphere LLC – Key Competitors 22
Genisphere LLC – Key Employees 23
Genisphere LLC – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Government and Public Interest 25
Nov 15, 2017: Genisphere Reports Safety of 3DNA Nanocarrier 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Genisphere LLC, Pharmaceuticals & Healthcare, Key Facts 2
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genisphere LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genisphere LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Genisphere LLC, Medical Devices Deals, 2012 to YTD 2018 9
Genisphere LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genisphere Raises USD7 Million in Financing 11
Genisphere Raises USD2 Million in Venture Financing 12
Genisphere Enters into Research Agreement with Sidney Kimmel 13
Genisphere Enters into Agreement with Inserm 14
Genisphere Enters into Research Agreement with University of Maryland 15
MedImmune Enters into Agreement with Genisphere 16
Genisphere Enters into Research Agreement with University of Pennsylvania 17
MultiCell Technologies Enters Into Agreement With Genisphere To Develop MCT-485 18
Genisphere Enters Into Agreement With Lankenau Institute for Medical Research To Develop Nanotherapeutics 19
Genisphere Receives License from LIMR Development 20
Genisphere Raises USD4 Million in Private Placement of Shares 21
Genisphere LLC, Key Competitors 22
Genisphere LLC, Key Employees 23

List of Figures
Genisphere LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genisphere LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genisphere LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Genisphere LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Merchants Bank Co., Ltd.:企業のM&A・事業提携・投資動向
    China Merchants Bank Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Merchants Bank Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Penske Corporation:企業の戦略的SWOT分析
    Penske Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • The Wendy’s Company:戦略・SWOT・企業財務分析
    The Wendy’s Company - Strategy, SWOT and Corporate Finance Report Summary The Wendy’s Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Iamgold Corporation:企業のM&A・事業提携・投資動向
    Iamgold Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iamgold Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • RigNet Inc (RNET):企業の財務・戦略的SWOT分析
    RigNet Inc (RNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cielo Wind Power, LP-エネルギー分野:企業M&A・提携分析
    Summary Cielo Wind Power, LP (Cielo Wind) is a wind power project development company. It designs, develops, owns and operates utility-grade wind power projects. The company provides a wide range of services including engineering, construction, operations and maintenance, land procurement, meteorolo …
  • NeuStar, Inc.:企業の戦略的SWOT分析
    NeuStar, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • IOOF Holdings Ltd (IFL):企業の財務・戦略的SWOT分析
    IOOF Holdings Ltd (IFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Crossject SA (ALCJ):医療機器:M&Aディール及び事業提携情報
    Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company’s pipeline products include sumatriptan for the treatment of migraines and cluster headaches; adrenaline for the treatment of anaphylactic shock; hydrocortisone for the treatment of acute adrena …
  • Systex Corp (6214):企業の財務・戦略的SWOT分析
    Systex Corp (6214) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Viralytics Ltd (VLA)-製薬・医療分野:企業M&A・提携分析
    Summary Viralytics Ltd (Viralytics), formerly Psiron Ltd is a provider of development and commercialisation of oncolytic immunotherapies. The company develops oncolytic immunotherapies for the treatment of different types of cancers. It offers cavataktm, a proprietary formulation for the common cold …
  • East Japan Railway Co:企業の戦略・SWOT・財務分析
    East Japan Railway Co - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Trane Inc:企業の戦略的SWOT分析
    Trane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • EnBW Energie Baden-Wurttemberg AG (EBK):企業の財務・戦略的SWOT分析
    EnBW Energie Baden-Wurttemberg AG (EBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • The Toronto-Dominion Bank:企業の戦略・SWOT・財務情報
    The Toronto-Dominion Bank - Strategy, SWOT and Corporate Finance Report Summary The Toronto-Dominion Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • EDF Energies Nouvelles SA:電力:M&Aディール及び事業提携情報
    Summary EDF Energies Nouvelles SA (EDF Energies Nouvelles) a subsidiary of Electricite de France S.A., develops, constructs, operates and maintains green electricity power plants in Europe and North America. The company produces electricity through various renewable energy sources such as wind, sola …
  • DCP Midstream Partners, LP:企業の戦略・SWOT・財務情報
    DCP Midstream Partners, LP - Strategy, SWOT and Corporate Finance Report Summary DCP Midstream Partners, LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • BoneSupport AB:企業の戦略的SWOT分析
    BoneSupport AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Deltex Medical Group Plc (DEMG):医療機器:M&Aディール及び事業提携情報
    Summary Deltex Medical Group Plc (Deltex Medical), formerly Chalkgrove Plc, is a medical device company that develops fluid management equipment and oesophageal doppler monitoring systems. The company offers products such as cardioQ-ODM+, probes, simulator, bougies, cerebral oximetry, video laryngos …
  • SGL Carbon SE (SGL):企業の財務・戦略的SWOT分析
    SGL Carbon SE (SGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆